Perkins Capital Management Inc Biolase, Inc Transaction History

Perkins Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 21, 2023	SELL	$0.07 - $0.34 $179,639 - $872,536	-2,566,285 Reduced 94.23%	157,196 $11,000
Q1 2023 May 09, 2023	BUY	$0.28 - $0.75 $749,639 - $2.01 Million	2,677,285 Added 5795.49%	2,723,481 $766,000
Q4 2022 Jan 26, 2023	SELL	$0.59 - $2.5 $50,665 - $214,685	-85,874 Reduced 65.02%	46,196 $30,000
Q3 2022 Oct 24, 2022	BUY	$2.43 - $5.53 $33,461 - $76,148	13,770 Added 11.64%	132,070 $321,000
Q2 2022 Jul 29, 2022	BUY	$3.42 - $8.75 $404,586 - $1.04 Million	118,300 New	118,300 $542,000

Ticker BIOL
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 8,260,180
Market Cap $82.6K
Description
BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive de...

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Perkins Capital Management Inc with notifications on news.